From biomarker identification and epigenetic analysis, to tumor response and tumor immunogenicity determination, advances in genomic technologies, like next-generation sequencing, are helping advance our understanding of interactions between the immune system and cancer, guiding therapeutic development. To learn more please visit the Illumina website.
Illumina: Advancing Biological Therapy with Immuno-oncology
Since the late 1800s, the field of immuno-oncology has been exploring the relationship between the immune system and the development, progression, and treatment of cancer.
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
